Lisa McDougall

757 total citations
18 papers, 571 citations indexed

About

Lisa McDougall is a scholar working on Radiology, Nuclear Medicine and Imaging, Epidemiology and Neurology. According to data from OpenAlex, Lisa McDougall has authored 18 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Epidemiology and 3 papers in Neurology. Recurrent topics in Lisa McDougall's work include Radiopharmaceutical Chemistry and Applications (10 papers), Neuroendocrine Tumor Research Advances (7 papers) and Medical Imaging Techniques and Applications (4 papers). Lisa McDougall is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (10 papers), Neuroendocrine Tumor Research Advances (7 papers) and Medical Imaging Techniques and Applications (4 papers). Lisa McDougall collaborates with scholars based in Switzerland, Germany and United States. Lisa McDougall's co-authors include Guillaume Nicolas, Damian Wild, Melpomeni Fani, Deepak Cyril D’Souza, Alan Breier, Walid Abi‐Saab, Ayşenil Belger, John H. Krystal, Nianjin Liu and Edward Perry and has published in prestigious journals such as SHILAP Revista de lepidopterología, Human Reproduction and Psychopharmacology.

In The Last Decade

Lisa McDougall

15 papers receiving 557 citations

Peers

Lisa McDougall
Valeriya Avdoshina United States
Rick Hermsen Netherlands
Yuhui Liu China
Daniel L. Crimmins United States
Anna Mach Poland
Z. Liu China
Lisa McDougall
Citations per year, relative to Lisa McDougall Lisa McDougall (= 1×) peers Hitoshi Takahashi

Countries citing papers authored by Lisa McDougall

Since Specialization
Citations

This map shows the geographic impact of Lisa McDougall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa McDougall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa McDougall more than expected).

Fields of papers citing papers by Lisa McDougall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa McDougall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa McDougall. The network helps show where Lisa McDougall may publish in the future.

Co-authorship network of co-authors of Lisa McDougall

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa McDougall. A scholar is included among the top collaborators of Lisa McDougall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa McDougall. Lisa McDougall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nicolas, Guillaume, Lisa McDougall, Felix Kaul, et al.. (2025). First-in-human administration of [61Cu]Cu-NODAGA-LM3 and head-to-head comparison with [68Ga]Ga-DOTA-TOC PET/CT as part of the phase I/II COPPER PET in NET study. European Journal of Nuclear Medicine and Molecular Imaging. 53(2). 710–712.
2.
McDougall, Lisa, Philipp Ritt, Nicholas P. van der Meulen, et al.. (2025). Bridging physics and practice: evaluating sensitivity, septal penetration, and detector dead time in terbium-161 gamma-camera imaging. EJNMMI Physics. 12(1). 81–81.
3.
Liang, Xi, et al.. (2024). Small Stomates and Xylem Vessels Associated With Freeze Tolerance in Winter Barley. Journal of Agronomy and Crop Science. 210(4). 1 indexed citations
4.
McDougall, Lisa, Andreas Bauman, Peter Bernhardt, et al.. (2024). Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study. Journal of Nuclear Medicine. 65(4). 573–579. 8 indexed citations
5.
Mansi, Rosalba, Luigi Del Pozzo, Raghuvir H. Gaonkar, et al.. (2024). 61Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging. Journal of Nuclear Medicine. 65(9). 1427–1434. 8 indexed citations
6.
Rottenburger, Christof, Michael Hentschel, Markus Fürstner, et al.. (2024). In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI Research. 14(1). 37–37. 6 indexed citations
7.
Nicolas, Guillaume, Lisa McDougall, David Schmid, et al.. (2024). First-in-human administration of [161Tb]Tb-SibuDAB and comparative dosimetry with standard [177Lu]Lu-PSMA-I&T as part of the PROGNOSTICS phase Ia study. European Journal of Nuclear Medicine and Molecular Imaging. 52(5). 1628–1630. 3 indexed citations
8.
McDougall, Lisa, Emanuel Christ, Guillaume Nicolas, et al.. (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European Journal of Nuclear Medicine and Molecular Imaging. 51(8). 2517–2519. 23 indexed citations
9.
Mansi, Rosalba, Luigi Del Pozzo, Raghuvir H. Gaonkar, et al.. (2024). Copper-61 is an advantageous alternative to gallium-68 for PET imaging of somatostatin receptor-expressing tumors: a head-to-head comparative preclinical study. SHILAP Revista de lepidopterología. 4. 1481343–1481343.
10.
Gaonkar, Raghuvir H., Luigi Del Pozzo, Lisa McDougall, et al.. (2021). SPECT Imaging of SST2-Expressing Tumors with 99mTc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers. Pharmaceuticals. 14(4). 300–300. 9 indexed citations
11.
Rottenburger, Christof, Guillaume Nicolas, Lisa McDougall, et al.. (2021). The CCK-2 receptor agonist Lu-177-PP-F11N for PRRT of medullary thyroid cancer – Recent results of the phase 1 “LUMED” Study. Nuklearmedizin - NuclearMedicine. 2 indexed citations
12.
Rottenburger, Christof, Guillaume Nicolas, Lisa McDougall, et al.. (2019). Evaluation of the CCK-2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma - final Results of the phase 0 'Lumed' Study. Endocrine Abstracts. 3 indexed citations
13.
Rottenburger, Christof, Guillaume Nicolas, Lisa McDougall, et al.. (2019). Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study. Journal of Nuclear Medicine. 61(4). 520–526. 67 indexed citations
14.
Nicolas, Guillaume, Rosalba Mansi, Lisa McDougall, et al.. (2017). Biodistribution, Pharmacokinetics, and Dosimetry of 177Lu-, 90Y-, and 111In-Labeled Somatostatin Receptor Antagonist OPS201 in Comparison to the Agonist 177Lu-DOTATATE: The Mass Effect. Journal of Nuclear Medicine. 58(9). 1435–1441. 112 indexed citations
15.
Dean, Matthew, et al.. (2014). Uterine glycogen metabolism in mink during estrus, embryonic diapause and pregnancy. Journal of Reproduction and Development. 60(6). 438–446. 19 indexed citations
17.
Lashen, Hany, et al.. (1999). Prediction of over-response to ovarian stimulation in an intrauterine insemination programme. Human Reproduction. 14(11). 2751–2754. 3 indexed citations
18.
Evans, A.C.O., Roger A. Pierson, A. García, et al.. (1996). Changes in circulating hormone concentrations, testes histology and testes ultrasonography during sexual maturation in beef bulls. Theriogenology. 46(2). 345–357. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026